Cencora Earnings
NYSE: CORHealth CareOther PharmaceuticalsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$4.54
Cencora earnings summary
Cencora is scheduled to report Sep/2026 earnings on Nov 4, 2026 before the market opens, with analysts expecting EPS of $4.54. In its most recent report on Aug 5, 2026 (Q3 2026), COR posted EPS of $3.94. Revenue for the quarter was $84.75 billion.
Quarterly EPS is up 11.9% from the same quarter a year earlier. Across the last 16 reports, COR shares moved an average of 2.4% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
COR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $3.94 | — | -2.1% |
| May 6, 2026 | — | $8.40 | — | -1.3% |
| Feb 4, 2026 | — | $2.87 | — | +0.4% |
| Nov 25, 2025 | — | $-1.74 | — | -7.9% |
| Aug 6, 2025 | — | $3.52 | — | +2.7% |
| May 7, 2025 | — | $3.68 | — | +2.6% |
| Feb 5, 2025 | — | $2.50 | — | -2.1% |
| Nov 26, 2024 | — | $0.04 | — | -3.2% |
| Jul 31, 2024 | — | $2.42 | — | -4.0% |
| May 1, 2024 | — | $2.09 | — | +0.3% |
| Jan 31, 2024 | — | $2.98 | — | -1.8% |
| Nov 21, 2023 | — | $1.72 | — | +1.4% |
| Aug 2, 2023 | — | $2.35 | — | +1.1% |
| May 2, 2023 | — | $2.13 | — | +1.8% |
| Feb 1, 2023 | — | $2.33 | — | +1.5% |
| Nov 22, 2022 | — | $1.40 | — | +3.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.